Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 3 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
ESC 23: The RIGHT Study
Author(s): Yan Yan , Gilles Montalescot Added: 2 years ago
ESC 23 — Dr Yan Yan (Beijing Anzhen Hospital, CN) and Prof Gilles Montalescot (Pitie Salpetriere APHP University Hospital,FR) discusses the findings from a comparison of anticoagulation prolongation vs no anticoagulation in STEMI patients post-primary PCI (RIGHT) (NCT03664180). The RIGHT study (Beijing Anzhen Hospital) aimed to evaluate the clinical efficacy and safety of anticoagulation… View more

Anticoagulation

MI/ACS
Revolutionising Thrombosis Treatment in ACS, SSP and AF: Bridging the Gaps With Next Generation Anticoagulation Strategies
Author(s): Davide Capodanno , Sneha Shah Jain Added: 5 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more

Anticoagulation

Electrophysiology & Arrhythmia
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 10 months ago

Anticoagulation

MI/ACS
AHA 24: The OPTION Trial
Author(s): Oussama M Wazni Added: 1 year ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more

Anticoagulation

Electrophysiology & Arrhythmia
AQUATIC Trial: Aspirin Plus Anticoagulation Harmful in High-Risk Chronic Coronary Syndrome
Added: 5 months ago Source:  Radcliffe Cardiology
Adding aspirin to an oral anticoagulant (OAC) regimen results in a higher risk of ischaemic events, all-cause mortality, and major bleeding in patients with chronic coronary syndrome (CCS) at high atherothrombotic risk, according to the results of the AQUATIC trial.¹ The study was stopped early due to an excess of deaths in the aspirin group.The AQUATIC trial was a multicentre, double-blind,… View more

Anticoagulation

Intervention
Coronary Artery Ectasia in Acute Coronary Syndrome
Author(s): Mahmoud Izraiq , Nail Alshoubaki , Omran A Abu-Dhaim , et al Added: 1 year ago

Anticoagulation

Intervention
ESC 24: The POPular PAUSE TAVI Trial
Author(s): Dirk-Jan van Ginkel Added: 1 year ago
ESC Congress 2024 — No benefit of continuing oral anticoagulation during TAVI procedure.Investigator, Dr Dirk-Jan van Ginkel (St Antonius Hospital, NL) joins us to discuss the result of the POPular PAUSE TAVI trial (NCT04437303; St Antonius Hospital). Presented for the first time at ESC 2024, this multicenter, randomized, open-label clinical trial compared the safety and efficacy of continuous… View more

Anticoagulation

Intervention
Isabelle Mahé
Job title: Professor of Internal Medicine
A specialist in cardiovascular disease by training, Isabelle Mahé is Professor of Internal Medicine at Paris Cité University, France. She is Head of the Internal Medicine Department at a teaching hospital (Louis Mourier, Assistance Publique Hôpitaux de Paris, Colombes, France), which includes an oncology unit and a cardiovascular disease unit.She is chair of the scientific council for the INNOVTE… View more
Your Questions Answered: Revolutionising Thrombosis Treatment in ACS, SSP and AF
Author(s): Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain Start date: Oct 06, 2025
Following the ESC 2025 symposium 'Revolutionising Thrombosis Treatment in ACS, SSP and AF – Bridging the Gaps With Next Generation Anticoagulation Strategies', this live Q&A webinar offers an exclusive chance to continue the conversation.Join Prof Carolyn Lam (Singapore, UK), Prof Jeffrey Weitz (Hamilton, CA) and Dr Sneha Shah Jain (Stanford, US) as they address your questions on stroke… View more

Anticoagulation

Electrophysiology & Arrhythmia